Ligand Reports Fourth Quarter and Full Year 2016 Financial Results
Go back to Ligand Reports Fourth Quarter and Full Year 2016 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 292.81 +2.74 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $290.07 | 52 Week High | $139.79 | |||
| Open | $291.00 | 52 Week Low | $82.07 | |||
| Day High | $292.85 | P/E | 680.95 | |||
| Day Low | $289.00 | EPS | $0.43 | |||
| Volume | 43,729 | |||||

